Single antibody infusions found promising against HIV

 A single antibody infusion can protect monkeys against infection with an HIV-like virus for up to 23 weeks, researchers have found.

Zinc deficiency may make inflammation worse in HIV+ patients

Deficiency of zinc can contribute to chronic inflammation among HIV-positive individuals, according to a new study.

Global HIV drive hampered without drugs for ''neglected'' West and Central Africa

A global drive to help curb the HIV epidemic by 2020 will fail unless millions of people with the virus in West and Central Africa receive life-saving drugs, Medecins Sans Frontieres (MSF) said on Wednesday.

Combined HIV, hepatitis C vaccination a possibility soon

An estimated 2.3 million people globally are co-infected with HIV and HCV. HCV is the leading cause of non-AIDS deaths in co-infected individuals.

HIV can develop resistance to gene-editing tool

The problem is that HIV is notoriously good at surviving and thriving with new mutations, so while many viruses are killed by the targeted approach, those that escape the CRISPR/Cas9 treatment become more difficult to target.

Researchers identify potent antibodies against HIV

 Scientists have developed a structure-based vaccine design that can jumpstart an effective immune response to HIV by rapidly offsetting antibodies against the virus, which so far have been unsuccessful.

Soon, HIV cure that snips out virus

The Temple University scientists believe that a gene editing technique, known as Crispr/Cas9, could pave the way for an injection to cure sufferers.

HIV drug may check skin cancer becoming drug-resistant

 A drug prescribed for patients affected with human immunodeficiency virus (HIV) infection is likely to prevent skin cancer developing resistance at the initial stages, suggests a new study.

Disposable biochip for simpler, affordable HIV diagnosis

There are about 50 microliters in a drop of blood.

Over 2 million co-infected with HIV, hepatitis C

 More than 2.3 million people globally are infected with both HIV and hepatitis C (HCV) viruses, finds a new study.

Beware! Dating sites helping spread HIV

According to a new study, more than 60% of gay and bisexual men diagnosed with HIV reported meeting sexual partners online in the preceding year.

Single drug dose can prevent early bone loss in HIV patients

The researchers assessed 343 individuals for eligibility, and 63 were selected and randomised to receive either ART and placebo, or ART and zoledronic acid.

Charlie Sheen stops taking HIV medication

Charlie Sheen stops taking HIV medication

Charlie Sheen admitted that he is no longer taking his HIV medication.

I drank to suffocate HIV anxiety: Charlie Sheen

I drank to suffocate HIV anxiety: Charlie Sheen

Charlie Sheen  took to drinking to suffocate his anxiety from HIV.

Anti-HIV drugs may be effective against Ebola

Interferon beta, the most potent inhibitor of Ebola which the team identified as a result of the screening, is now part of a clinical trial of individuals who were infected with Ebola during the recent outbreak in Guinea.

Early sex puts teenagers at high infection risk

Responses of 22,381 adolescents with sexual intercourse experience were included for the analysis.

Govt adds Cancer, HIV, Hepatitis C to list of essential medicines

The Government has added 106 drugs including that of Cancer, HIV/AIDS and Hepatitis C to the list of essential medicines.

Training doctors linked to reduced sexually transmitted infections

The study was a randomized controlled trial of an intensive, customized training programme for physicians in sexually transmitted infections.

Price cap in 530 essential medicines, including 47 for cancer

The National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices for 530 essential medicines, including 47 for cancer and 22 for HIV, Lok Sabha was informed today.

No fresh HIV case detected during July-Oct in Mizoram: MSACS

The MSACS has detected 10,448 HIV cases since October 1990 till June this year.